nodes	percent_of_prediction	percent_of_DWPC	metapath
Vandetanib—thyroid cancer—mediastinal cancer	0.864	1	CtDrD
Vandetanib—RET—Posttranslational regulation of adherens junction stability and dissassembly—PTPN1—mediastinal cancer	0.00277	0.0675	CbGpPWpGaD
Vandetanib—RET—parathyroid gland—mediastinal cancer	0.00271	0.0284	CbGeAlD
Vandetanib—KDR—Signaling events mediated by TCPTP—PTPN1—mediastinal cancer	0.00171	0.0417	CbGpPWpGaD
Vandetanib—LYN—Growth hormone receptor signaling—PTPN1—mediastinal cancer	0.00167	0.0406	CbGpPWpGaD
Vandetanib—MAP4K5—Insulin Signaling—PTPN1—mediastinal cancer	0.00164	0.04	CbGpPWpGaD
Vandetanib—VEGFA—Signaling events mediated by TCPTP—PTPN1—mediastinal cancer	0.00154	0.0375	CbGpPWpGaD
Vandetanib—BLK—Signaling events mediated by PTP1B—PTPN1—mediastinal cancer	0.0015	0.0365	CbGpPWpGaD
Vandetanib—FGR—Signaling events mediated by PTP1B—PTPN1—mediastinal cancer	0.00149	0.0364	CbGpPWpGaD
Vandetanib—BLK—hematopoietic system—mediastinal cancer	0.00122	0.0128	CbGeAlD
Vandetanib—YES1—Signaling events mediated by PTP1B—PTPN1—mediastinal cancer	0.0012	0.0294	CbGpPWpGaD
Vandetanib—PTK6—hematopoietic system—mediastinal cancer	0.00116	0.0121	CbGeAlD
Vandetanib—PDGFRB—Signaling events mediated by TCPTP—PTPN1—mediastinal cancer	0.00113	0.0276	CbGpPWpGaD
Vandetanib—SRC—Integrin alphaIIb beta3 signaling—PTPN1—mediastinal cancer	0.0011	0.0268	CbGpPWpGaD
Vandetanib—PTK6—bronchus—mediastinal cancer	0.00104	0.0109	CbGeAlD
Vandetanib—PLK4—hematopoietic system—mediastinal cancer	0.000953	0.00999	CbGeAlD
Vandetanib—ABL1—Posttranslational regulation of adherens junction stability and dissassembly—PTPN1—mediastinal cancer	0.000953	0.0232	CbGpPWpGaD
Vandetanib—FYN—Posttranslational regulation of adherens junction stability and dissassembly—PTPN1—mediastinal cancer	0.000943	0.023	CbGpPWpGaD
Vandetanib—EGFR—Signaling events mediated by TCPTP—PTPN1—mediastinal cancer	0.000942	0.023	CbGpPWpGaD
Vandetanib—PTK6—trachea—mediastinal cancer	0.000936	0.0098	CbGeAlD
Vandetanib—PDGFRB—Signaling events mediated by PTP1B—PTPN1—mediastinal cancer	0.000918	0.0224	CbGpPWpGaD
Vandetanib—LYN—Signaling events mediated by PTP1B—PTPN1—mediastinal cancer	0.000898	0.0219	CbGpPWpGaD
Vandetanib—TYRO3—hematopoietic system—mediastinal cancer	0.000896	0.00938	CbGeAlD
Vandetanib—LYN—hematopoietic system—mediastinal cancer	0.000891	0.00933	CbGeAlD
Vandetanib—FYN—Signaling events mediated by PTP1B—PTPN1—mediastinal cancer	0.000884	0.0216	CbGpPWpGaD
Vandetanib—BLK—lymphoid tissue—mediastinal cancer	0.00086	0.00901	CbGeAlD
Vandetanib—SRC—Platelet Aggregation (Plug Formation)—PTPN1—mediastinal cancer	0.000856	0.0209	CbGpPWpGaD
Vandetanib—RET—neck—mediastinal cancer	0.00082	0.00859	CbGeAlD
Vandetanib—EGFR—Posttranslational regulation of adherens junction stability and dissassembly—PTPN1—mediastinal cancer	0.000815	0.0199	CbGpPWpGaD
Vandetanib—SRC—Signaling events mediated by TCPTP—PTPN1—mediastinal cancer	0.000804	0.0196	CbGpPWpGaD
Vandetanib—BMPR1B—bronchus—mediastinal cancer	0.00079	0.00827	CbGeAlD
Vandetanib—EGFR—Signaling events mediated by PTP1B—PTPN1—mediastinal cancer	0.000764	0.0186	CbGpPWpGaD
Vandetanib—FLT3—hematopoietic system—mediastinal cancer	0.000761	0.00798	CbGeAlD
Vandetanib—BLK—PDGFR-beta signaling pathway—PTPN1—mediastinal cancer	0.000742	0.0181	CbGpPWpGaD
Vandetanib—FGR—PDGFR-beta signaling pathway—PTPN1—mediastinal cancer	0.00074	0.018	CbGpPWpGaD
Vandetanib—LCK—Signaling events mediated by PTP1B—PTPN1—mediastinal cancer	0.000736	0.0179	CbGpPWpGaD
Vandetanib—LTK—lung—mediastinal cancer	0.000701	0.00735	CbGeAlD
Vandetanib—SRC—Posttranslational regulation of adherens junction stability and dissassembly—PTPN1—mediastinal cancer	0.000695	0.0169	CbGpPWpGaD
Vandetanib—FLT4—hematopoietic system—mediastinal cancer	0.000692	0.00725	CbGeAlD
Vandetanib—RIPK2—hematopoietic system—mediastinal cancer	0.000688	0.00721	CbGeAlD
Vandetanib—PTK6—lung—mediastinal cancer	0.000672	0.00704	CbGeAlD
Vandetanib—IRAK4—hematopoietic system—mediastinal cancer	0.000672	0.00704	CbGeAlD
Vandetanib—PLK4—lymphoid tissue—mediastinal cancer	0.000671	0.00703	CbGeAlD
Vandetanib—FYN—Leptin signaling pathway—PTPN1—mediastinal cancer	0.00066	0.0161	CbGpPWpGaD
Vandetanib—ERBB3—hematopoietic system—mediastinal cancer	0.000658	0.0069	CbGeAlD
Vandetanib—SRC—Signaling events mediated by PTP1B—PTPN1—mediastinal cancer	0.000652	0.0159	CbGpPWpGaD
Vandetanib—TYRO3—lymphoid tissue—mediastinal cancer	0.00063	0.00661	CbGeAlD
Vandetanib—LYN—lymphoid tissue—mediastinal cancer	0.000627	0.00657	CbGeAlD
Vandetanib—RIPK2—bronchus—mediastinal cancer	0.000619	0.00649	CbGeAlD
Vandetanib—MKNK1—hematopoietic system—mediastinal cancer	0.000618	0.00648	CbGeAlD
Vandetanib—VEGFA—bronchus—mediastinal cancer	0.000618	0.00647	CbGeAlD
Vandetanib—PLK4—bone marrow—mediastinal cancer	0.000611	0.0064	CbGeAlD
Vandetanib—KDR—neck—mediastinal cancer	0.000611	0.0064	CbGeAlD
Vandetanib—FGR—hematopoietic system—mediastinal cancer	0.000611	0.0064	CbGeAlD
Vandetanib—RET—hematopoietic system—mediastinal cancer	0.000611	0.0064	CbGeAlD
Vandetanib—AXL—hematopoietic system—mediastinal cancer	0.000608	0.00637	CbGeAlD
Vandetanib—IRAK4—bronchus—mediastinal cancer	0.000605	0.00633	CbGeAlD
Vandetanib—YES1—PDGFR-beta signaling pathway—PTPN1—mediastinal cancer	0.000597	0.0146	CbGpPWpGaD
Vandetanib—MAP2K5—Insulin Signaling—PTPN1—mediastinal cancer	0.000579	0.0141	CbGpPWpGaD
Vandetanib—FYN—hematopoietic system—mediastinal cancer	0.000569	0.00596	CbGeAlD
Vandetanib—STK35—cardiac atrium—mediastinal cancer	0.000566	0.00593	CbGeAlD
Vandetanib—BMPR1B—thyroid gland—mediastinal cancer	0.000561	0.00588	CbGeAlD
Vandetanib—MKNK1—bronchus—mediastinal cancer	0.000556	0.00583	CbGeAlD
Vandetanib—MAP4K5—hematopoietic system—mediastinal cancer	0.000556	0.00583	CbGeAlD
Vandetanib—TEK—hematopoietic system—mediastinal cancer	0.000556	0.00583	CbGeAlD
Vandetanib—RIPK2—trachea—mediastinal cancer	0.000556	0.00582	CbGeAlD
Vandetanib—VEGFA—trachea—mediastinal cancer	0.000554	0.00581	CbGeAlD
Vandetanib—PLK4—lung—mediastinal cancer	0.000554	0.0058	CbGeAlD
Vandetanib—FMO1—trachea—mediastinal cancer	0.000552	0.00578	CbGeAlD
Vandetanib—LCK—bronchus—mediastinal cancer	0.00055	0.00576	CbGeAlD
Vandetanib—IRAK4—trachea—mediastinal cancer	0.000543	0.00569	CbGeAlD
Vandetanib—FLT3—lymphoid tissue—mediastinal cancer	0.000536	0.00562	CbGeAlD
Vandetanib—ERBB3—trachea—mediastinal cancer	0.000532	0.00558	CbGeAlD
Vandetanib—FMO3—bronchus—mediastinal cancer	0.000531	0.00556	CbGeAlD
Vandetanib—PDGFRB—neck—mediastinal cancer	0.000529	0.00554	CbGeAlD
Vandetanib—SLK—bronchus—mediastinal cancer	0.000527	0.00552	CbGeAlD
Vandetanib—RIPK2—cardiac atrium—mediastinal cancer	0.000522	0.00547	CbGeAlD
Vandetanib—VEGFA—cardiac atrium—mediastinal cancer	0.000521	0.00546	CbGeAlD
Vandetanib—YES1—hematopoietic system—mediastinal cancer	0.000514	0.00538	CbGeAlD
Vandetanib—FYN—bronchus—mediastinal cancer	0.000512	0.00537	CbGeAlD
Vandetanib—BMPR1B—lung—mediastinal cancer	0.00051	0.00534	CbGeAlD
Vandetanib—MAP3K19—lung—mediastinal cancer	0.00051	0.00534	CbGeAlD
Vandetanib—STK10—hematopoietic system—mediastinal cancer	0.000509	0.00533	CbGeAlD
Vandetanib—TEK—bronchus—mediastinal cancer	0.000501	0.00525	CbGeAlD
Vandetanib—MAP4K5—bronchus—mediastinal cancer	0.000501	0.00525	CbGeAlD
Vandetanib—SRC—hematopoietic system—mediastinal cancer	0.000494	0.00518	CbGeAlD
Vandetanib—LCK—trachea—mediastinal cancer	0.000494	0.00517	CbGeAlD
Vandetanib—AXL—trachea—mediastinal cancer	0.000492	0.00515	CbGeAlD
Vandetanib—FLT3—bone marrow—mediastinal cancer	0.000488	0.00511	CbGeAlD
Vandetanib—FLT4—lymphoid tissue—mediastinal cancer	0.000487	0.0051	CbGeAlD
Vandetanib—SRC—Leptin signaling pathway—PTPN1—mediastinal cancer	0.000486	0.0119	CbGpPWpGaD
Vandetanib—BLK—lymph node—mediastinal cancer	0.000485	0.00508	CbGeAlD
Vandetanib—LTK—lymph node—mediastinal cancer	0.00048	0.00502	CbGeAlD
Vandetanib—EPHB6—bronchus—mediastinal cancer	0.000479	0.00501	CbGeAlD
Vandetanib—STK35—thyroid gland—mediastinal cancer	0.000477	0.005	CbGeAlD
Vandetanib—SLK—trachea—mediastinal cancer	0.000473	0.00496	CbGeAlD
Vandetanib—IRAK4—lymphoid tissue—mediastinal cancer	0.000473	0.00495	CbGeAlD
Vandetanib—MKNK1—cardiac atrium—mediastinal cancer	0.000469	0.00492	CbGeAlD
Vandetanib—ABL2—thyroid gland—mediastinal cancer	0.000465	0.00487	CbGeAlD
Vandetanib—ERBB3—lymphoid tissue—mediastinal cancer	0.000464	0.00486	CbGeAlD
Vandetanib—YES1—bronchus—mediastinal cancer	0.000462	0.00484	CbGeAlD
Vandetanib—SRC—Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)—PTPN1—mediastinal cancer	0.000462	0.0113	CbGpPWpGaD
Vandetanib—AXL—cardiac atrium—mediastinal cancer	0.000462	0.00484	CbGeAlD
Vandetanib—FYN—trachea—mediastinal cancer	0.00046	0.00482	CbGeAlD
Vandetanib—STK10—bronchus—mediastinal cancer	0.000458	0.0048	CbGeAlD
Vandetanib—PDGFRB—PDGFR-beta signaling pathway—PTPN1—mediastinal cancer	0.000455	0.0111	CbGpPWpGaD
Vandetanib—KDR—hematopoietic system—mediastinal cancer	0.000455	0.00476	CbGeAlD
Vandetanib—EGFR—thyroid gland—mediastinal cancer	0.000454	0.00475	CbGeAlD
Vandetanib—MAP4K5—trachea—mediastinal cancer	0.00045	0.00471	CbGeAlD
Vandetanib—IRAK4—Cytokine Signaling in Immune system—PTPN1—mediastinal cancer	0.000448	0.0109	CbGpPWpGaD
Vandetanib—LYN—PDGFR-beta signaling pathway—PTPN1—mediastinal cancer	0.000445	0.0109	CbGpPWpGaD
Vandetanib—SLK—cardiac atrium—mediastinal cancer	0.000444	0.00466	CbGeAlD
Vandetanib—FLT4—bone marrow—mediastinal cancer	0.000443	0.00464	CbGeAlD
Vandetanib—ABL1—PDGFR-beta signaling pathway—PTPN1—mediastinal cancer	0.000443	0.0108	CbGpPWpGaD
Vandetanib—FLT3—lung—mediastinal cancer	0.000442	0.00463	CbGeAlD
Vandetanib—FLT4—thyroid gland—mediastinal cancer	0.000442	0.00463	CbGeAlD
Vandetanib—RIPK2—bone marrow—mediastinal cancer	0.000441	0.00462	CbGeAlD
Vandetanib—RIPK2—thyroid gland—mediastinal cancer	0.00044	0.00461	CbGeAlD
Vandetanib—VEGFA—bone marrow—mediastinal cancer	0.00044	0.00461	CbGeAlD
Vandetanib—VEGFA—thyroid gland—mediastinal cancer	0.000439	0.0046	CbGeAlD
Vandetanib—FYN—PDGFR-beta signaling pathway—PTPN1—mediastinal cancer	0.000438	0.0107	CbGpPWpGaD
Vandetanib—FMO1—thyroid gland—mediastinal cancer	0.000436	0.00457	CbGeAlD
Vandetanib—MKNK1—lymphoid tissue—mediastinal cancer	0.000435	0.00456	CbGeAlD
Vandetanib—STK35—lung—mediastinal cancer	0.000433	0.00454	CbGeAlD
Vandetanib—FYN—cardiac atrium—mediastinal cancer	0.000432	0.00453	CbGeAlD
Vandetanib—IRAK4—bone marrow—mediastinal cancer	0.000431	0.00451	CbGeAlD
Vandetanib—RET—lymphoid tissue—mediastinal cancer	0.00043	0.0045	CbGeAlD
Vandetanib—FGR—lymphoid tissue—mediastinal cancer	0.00043	0.0045	CbGeAlD
Vandetanib—EPHB6—trachea—mediastinal cancer	0.00043	0.0045	CbGeAlD
Vandetanib—IRAK4—thyroid gland—mediastinal cancer	0.00043	0.0045	CbGeAlD
Vandetanib—AXL—lymphoid tissue—mediastinal cancer	0.000428	0.00449	CbGeAlD
Vandetanib—TEK—cardiac atrium—mediastinal cancer	0.000422	0.00442	CbGeAlD
Vandetanib—MAP4K5—cardiac atrium—mediastinal cancer	0.000422	0.00442	CbGeAlD
Vandetanib—ABL2—lung—mediastinal cancer	0.000422	0.00442	CbGeAlD
Vandetanib—ERBB3—thyroid gland—mediastinal cancer	0.000421	0.00441	CbGeAlD
Vandetanib—YES1—trachea—mediastinal cancer	0.000415	0.00435	CbGeAlD
Vandetanib—EGFR—lung—mediastinal cancer	0.000412	0.00432	CbGeAlD
Vandetanib—MAP2K5—bronchus—mediastinal cancer	0.000409	0.00429	CbGeAlD
Vandetanib—KDR—bronchus—mediastinal cancer	0.000409	0.00429	CbGeAlD
Vandetanib—RIPK2—Cytokine Signaling in Immune system—PTPN1—mediastinal cancer	0.000405	0.00987	CbGpPWpGaD
Vandetanib—EPHB6—cardiac atrium—mediastinal cancer	0.000404	0.00423	CbGeAlD
Vandetanib—FLT4—lung—mediastinal cancer	0.000402	0.00421	CbGeAlD
Vandetanib—FYN—lymphoid tissue—mediastinal cancer	0.000401	0.0042	CbGeAlD
Vandetanib—RIPK2—lung—mediastinal cancer	0.000399	0.00419	CbGeAlD
Vandetanib—VEGFA—lung—mediastinal cancer	0.000398	0.00417	CbGeAlD
Vandetanib—FMO1—lung—mediastinal cancer	0.000396	0.00415	CbGeAlD
Vandetanib—MKNK1—bone marrow—mediastinal cancer	0.000396	0.00415	CbGeAlD
Vandetanib—MKNK1—thyroid gland—mediastinal cancer	0.000395	0.00414	CbGeAlD
Vandetanib—PDGFRB—hematopoietic system—mediastinal cancer	0.000393	0.00412	CbGeAlD
Vandetanib—VEGFA—Platelet activation, signaling and aggregation—PTPN1—mediastinal cancer	0.000392	0.00955	CbGpPWpGaD
Vandetanib—TEK—lymphoid tissue—mediastinal cancer	0.000392	0.0041	CbGeAlD
Vandetanib—MAP4K5—lymphoid tissue—mediastinal cancer	0.000392	0.0041	CbGeAlD
Vandetanib—FGR—bone marrow—mediastinal cancer	0.000391	0.0041	CbGeAlD
Vandetanib—LCK—bone marrow—mediastinal cancer	0.000391	0.0041	CbGeAlD
Vandetanib—FGR—thyroid gland—mediastinal cancer	0.00039	0.00409	CbGeAlD
Vandetanib—RET—thyroid gland—mediastinal cancer	0.00039	0.00409	CbGeAlD
Vandetanib—LCK—thyroid gland—mediastinal cancer	0.00039	0.00409	CbGeAlD
Vandetanib—IRAK4—lung—mediastinal cancer	0.00039	0.00409	CbGeAlD
Vandetanib—YES1—cardiac atrium—mediastinal cancer	0.00039	0.00409	CbGeAlD
Vandetanib—AXL—thyroid gland—mediastinal cancer	0.000389	0.00407	CbGeAlD
Vandetanib—ERBB3—lung—mediastinal cancer	0.000382	0.00401	CbGeAlD
Vandetanib—PLK4—lymph node—mediastinal cancer	0.000379	0.00397	CbGeAlD
Vandetanib—FMO3—thyroid gland—mediastinal cancer	0.000377	0.00395	CbGeAlD
Vandetanib—SLK—bone marrow—mediastinal cancer	0.000375	0.00393	CbGeAlD
Vandetanib—SRC—cardiac atrium—mediastinal cancer	0.000375	0.00393	CbGeAlD
Vandetanib—TEK—Hemostasis—PTPN1—mediastinal cancer	0.000375	0.00914	CbGpPWpGaD
Vandetanib—SLK—thyroid gland—mediastinal cancer	0.000374	0.00392	CbGeAlD
Vandetanib—ORM1—hematopoietic system—mediastinal cancer	0.000369	0.00387	CbGeAlD
Vandetanib—KDR—trachea—mediastinal cancer	0.000367	0.00385	CbGeAlD
Vandetanib—MAP2K5—trachea—mediastinal cancer	0.000367	0.00385	CbGeAlD
Vandetanib—LCK—PDGFR-beta signaling pathway—PTPN1—mediastinal cancer	0.000365	0.0089	CbGpPWpGaD
Vandetanib—FYN—bone marrow—mediastinal cancer	0.000365	0.00382	CbGeAlD
Vandetanib—FYN—thyroid gland—mediastinal cancer	0.000364	0.00381	CbGeAlD
Vandetanib—YES1—lymphoid tissue—mediastinal cancer	0.000362	0.00379	CbGeAlD
Vandetanib—MKNK1—lung—mediastinal cancer	0.000359	0.00376	CbGeAlD
Vandetanib—STK10—lymphoid tissue—mediastinal cancer	0.000358	0.00375	CbGeAlD
Vandetanib—MAP4K5—bone marrow—mediastinal cancer	0.000357	0.00374	CbGeAlD
Vandetanib—MAP4K5—thyroid gland—mediastinal cancer	0.000356	0.00373	CbGeAlD
Vandetanib—TEK—thyroid gland—mediastinal cancer	0.000356	0.00373	CbGeAlD
Vandetanib—LCK—lung—mediastinal cancer	0.000355	0.00372	CbGeAlD
Vandetanib—FGR—lung—mediastinal cancer	0.000355	0.00372	CbGeAlD
Vandetanib—PDGFRB—bronchus—mediastinal cancer	0.000354	0.00371	CbGeAlD
Vandetanib—AXL—lung—mediastinal cancer	0.000353	0.0037	CbGeAlD
Vandetanib—ABL1—hematopoietic system—mediastinal cancer	0.000351	0.00367	CbGeAlD
Vandetanib—BMPR1B—lymph node—mediastinal cancer	0.000349	0.00365	CbGeAlD
Vandetanib—SRC—lymphoid tissue—mediastinal cancer	0.000348	0.00364	CbGeAlD
Vandetanib—MAP2K5—cardiac atrium—mediastinal cancer	0.000345	0.00362	CbGeAlD
Vandetanib—KDR—cardiac atrium—mediastinal cancer	0.000345	0.00362	CbGeAlD
Vandetanib—FMO3—lung—mediastinal cancer	0.000342	0.00359	CbGeAlD
Vandetanib—SLK—lung—mediastinal cancer	0.00034	0.00356	CbGeAlD
Vandetanib—EPHB6—thyroid gland—mediastinal cancer	0.00034	0.00356	CbGeAlD
Vandetanib—FYN—lung—mediastinal cancer	0.000331	0.00346	CbGeAlD
Vandetanib—YES1—bone marrow—mediastinal cancer	0.000329	0.00345	CbGeAlD
Vandetanib—YES1—thyroid gland—mediastinal cancer	0.000328	0.00344	CbGeAlD
Vandetanib—STK10—bone marrow—mediastinal cancer	0.000326	0.00342	CbGeAlD
Vandetanib—STK10—thyroid gland—mediastinal cancer	0.000326	0.00341	CbGeAlD
Vandetanib—SRC—PDGFR-beta signaling pathway—PTPN1—mediastinal cancer	0.000323	0.00788	CbGpPWpGaD
Vandetanib—MAP4K5—lung—mediastinal cancer	0.000323	0.00338	CbGeAlD
Vandetanib—TEK—lung—mediastinal cancer	0.000323	0.00338	CbGeAlD
Vandetanib—KDR—lymphoid tissue—mediastinal cancer	0.00032	0.00335	CbGeAlD
Vandetanib—PDGFRB—trachea—mediastinal cancer	0.000318	0.00333	CbGeAlD
Vandetanib—SRC—thyroid gland—mediastinal cancer	0.000316	0.00331	CbGeAlD
Vandetanib—ABL1—bronchus—mediastinal cancer	0.000316	0.00331	CbGeAlD
Vandetanib—YES1—Cytokine Signaling in Immune system—PTPN1—mediastinal cancer	0.000313	0.00764	CbGpPWpGaD
Vandetanib—EPHB6—lung—mediastinal cancer	0.000309	0.00323	CbGeAlD
Vandetanib—FLT3—lymph node—mediastinal cancer	0.000302	0.00317	CbGeAlD
Vandetanib—PDGFRB—cardiac atrium—mediastinal cancer	0.000299	0.00313	CbGeAlD
Vandetanib—YES1—lung—mediastinal cancer	0.000298	0.00313	CbGeAlD
Vandetanib—STK35—lymph node—mediastinal cancer	0.000296	0.0031	CbGeAlD
Vandetanib—STK10—lung—mediastinal cancer	0.000296	0.0031	CbGeAlD
Vandetanib—KDR—bone marrow—mediastinal cancer	0.000291	0.00305	CbGeAlD
Vandetanib—KDR—thyroid gland—mediastinal cancer	0.000291	0.00305	CbGeAlD
Vandetanib—MAP2K5—thyroid gland—mediastinal cancer	0.000291	0.00305	CbGeAlD
Vandetanib—ABL2—lymph node—mediastinal cancer	0.000289	0.00303	CbGeAlD
Vandetanib—SRC—lung—mediastinal cancer	0.000287	0.00301	CbGeAlD
Vandetanib—ABL1—trachea—mediastinal cancer	0.000283	0.00297	CbGeAlD
Vandetanib—LYN—Platelet activation, signaling and aggregation—PTPN1—mediastinal cancer	0.000282	0.00688	CbGpPWpGaD
Vandetanib—EGFR—lymph node—mediastinal cancer	0.000282	0.00295	CbGeAlD
Vandetanib—FYN—Platelet activation, signaling and aggregation—PTPN1—mediastinal cancer	0.000278	0.00677	CbGpPWpGaD
Vandetanib—PDGFRB—lymphoid tissue—mediastinal cancer	0.000277	0.0029	CbGeAlD
Vandetanib—FLT4—lymph node—mediastinal cancer	0.000275	0.00288	CbGeAlD
Vandetanib—RIPK2—lymph node—mediastinal cancer	0.000273	0.00286	CbGeAlD
Vandetanib—VEGFA—lymph node—mediastinal cancer	0.000272	0.00285	CbGeAlD
Vandetanib—FMO1—lymph node—mediastinal cancer	0.000271	0.00284	CbGeAlD
Vandetanib—IRAK4—lymph node—mediastinal cancer	0.000267	0.0028	CbGeAlD
Vandetanib—ABL1—cardiac atrium—mediastinal cancer	0.000266	0.00279	CbGeAlD
Vandetanib—KDR—lung—mediastinal cancer	0.000264	0.00277	CbGeAlD
Vandetanib—MAP2K5—lung—mediastinal cancer	0.000264	0.00277	CbGeAlD
Vandetanib—ERBB3—lymph node—mediastinal cancer	0.000262	0.00274	CbGeAlD
Vandetanib—PDGFRB—bone marrow—mediastinal cancer	0.000252	0.00264	CbGeAlD
Vandetanib—PDGFRB—thyroid gland—mediastinal cancer	0.000252	0.00264	CbGeAlD
Vandetanib—ABL1—lymphoid tissue—mediastinal cancer	0.000247	0.00259	CbGeAlD
Vandetanib—MKNK1—lymph node—mediastinal cancer	0.000246	0.00257	CbGeAlD
Vandetanib—FGR—lymph node—mediastinal cancer	0.000243	0.00254	CbGeAlD
Vandetanib—RET—lymph node—mediastinal cancer	0.000243	0.00254	CbGeAlD
Vandetanib—LCK—lymph node—mediastinal cancer	0.000243	0.00254	CbGeAlD
Vandetanib—FGR—Hemostasis—PTPN1—mediastinal cancer	0.000242	0.00589	CbGpPWpGaD
Vandetanib—AXL—lymph node—mediastinal cancer	0.000242	0.00253	CbGeAlD
Vandetanib—ABCC1—bronchus—mediastinal cancer	0.00024	0.00252	CbGeAlD
Vandetanib—ORM1—bone marrow—mediastinal cancer	0.000237	0.00248	CbGeAlD
Vandetanib—FMO3—lymph node—mediastinal cancer	0.000234	0.00245	CbGeAlD
Vandetanib—LYN—Cytokine Signaling in Immune system—PTPN1—mediastinal cancer	0.000234	0.00569	CbGpPWpGaD
Vandetanib—SLK—lymph node—mediastinal cancer	0.000233	0.00244	CbGeAlD
Vandetanib—LCK—Platelet activation, signaling and aggregation—PTPN1—mediastinal cancer	0.000231	0.00564	CbGpPWpGaD
Vandetanib—FYN—Cytokine Signaling in Immune system—PTPN1—mediastinal cancer	0.00023	0.0056	CbGpPWpGaD
Vandetanib—PDGFRB—lung—mediastinal cancer	0.000229	0.00239	CbGeAlD
Vandetanib—FYN—lymph node—mediastinal cancer	0.000226	0.00237	CbGeAlD
Vandetanib—ABL1—bone marrow—mediastinal cancer	0.000225	0.00236	CbGeAlD
Vandetanib—ABL1—thyroid gland—mediastinal cancer	0.000224	0.00235	CbGeAlD
Vandetanib—TEK—lymph node—mediastinal cancer	0.000221	0.00231	CbGeAlD
Vandetanib—MAP4K5—lymph node—mediastinal cancer	0.000221	0.00231	CbGeAlD
Vandetanib—ABCC1—trachea—mediastinal cancer	0.000216	0.00226	CbGeAlD
Vandetanib—ORM1—lung—mediastinal cancer	0.000214	0.00225	CbGeAlD
Vandetanib—EPHB6—lymph node—mediastinal cancer	0.000211	0.00221	CbGeAlD
Vandetanib—SRC—Platelet activation, signaling and aggregation—PTPN1—mediastinal cancer	0.000205	0.00499	CbGpPWpGaD
Vandetanib—YES1—lymph node—mediastinal cancer	0.000204	0.00214	CbGeAlD
Vandetanib—ABL1—lung—mediastinal cancer	0.000204	0.00213	CbGeAlD
Vandetanib—ABCC1—cardiac atrium—mediastinal cancer	0.000203	0.00212	CbGeAlD
Vandetanib—STK10—lymph node—mediastinal cancer	0.000202	0.00212	CbGeAlD
Vandetanib—VEGFA—Hemostasis—PTPN1—mediastinal cancer	0.000202	0.00492	CbGpPWpGaD
Vandetanib—SRC—lymph node—mediastinal cancer	0.000196	0.00206	CbGeAlD
Vandetanib—YES1—Hemostasis—PTPN1—mediastinal cancer	0.000195	0.00476	CbGpPWpGaD
Vandetanib—LCK—Cytokine Signaling in Immune system—PTPN1—mediastinal cancer	0.000191	0.00467	CbGpPWpGaD
Vandetanib—AXL—Signaling Pathways—PTPN1—mediastinal cancer	0.000184	0.00447	CbGpPWpGaD
Vandetanib—KDR—lymph node—mediastinal cancer	0.000181	0.00189	CbGeAlD
Vandetanib—MAP2K5—lymph node—mediastinal cancer	0.000181	0.00189	CbGeAlD
Vandetanib—ABCC1—thyroid gland—mediastinal cancer	0.000171	0.00179	CbGeAlD
Vandetanib—BMPR1B—Signaling Pathways—PTPN1—mediastinal cancer	0.000168	0.00409	CbGpPWpGaD
Vandetanib—PDGFRB—lymph node—mediastinal cancer	0.000156	0.00164	CbGeAlD
Vandetanib—ABCC1—lung—mediastinal cancer	0.000155	0.00163	CbGeAlD
Vandetanib—CYP3A4—hematopoietic system—mediastinal cancer	0.000154	0.00161	CbGeAlD
Vandetanib—FLT4—Signaling Pathways—PTPN1—mediastinal cancer	0.000154	0.00374	CbGpPWpGaD
Vandetanib—ORM1—lymph node—mediastinal cancer	0.000147	0.00154	CbGeAlD
Vandetanib—IRAK4—Immune System—PTPN1—mediastinal cancer	0.000146	0.00356	CbGpPWpGaD
Vandetanib—LYN—Hemostasis—PTPN1—mediastinal cancer	0.000146	0.00355	CbGpPWpGaD
Vandetanib—ABL1—Hemostasis—PTPN1—mediastinal cancer	0.000145	0.00353	CbGpPWpGaD
Vandetanib—FYN—Hemostasis—PTPN1—mediastinal cancer	0.000143	0.00349	CbGpPWpGaD
Vandetanib—ABCG2—bone marrow—mediastinal cancer	0.000142	0.00149	CbGeAlD
Vandetanib—ABCG2—thyroid gland—mediastinal cancer	0.000141	0.00148	CbGeAlD
Vandetanib—ABL1—lymph node—mediastinal cancer	0.000139	0.00146	CbGeAlD
Vandetanib—ALB—Platelet activation, signaling and aggregation—PTPN1—mediastinal cancer	0.000138	0.00337	CbGpPWpGaD
Vandetanib—RIPK2—Immune System—PTPN1—mediastinal cancer	0.000132	0.00322	CbGpPWpGaD
Vandetanib—ALB—lymph node—mediastinal cancer	0.000129	0.00135	CbGeAlD
Vandetanib—ABCG2—lung—mediastinal cancer	0.000128	0.00135	CbGeAlD
Vandetanib—BLK—Immune System—PTPN1—mediastinal cancer	0.000127	0.0031	CbGpPWpGaD
Vandetanib—MKNK1—Signaling Pathways—PTPN1—mediastinal cancer	0.000127	0.0031	CbGpPWpGaD
Vandetanib—FGR—Immune System—PTPN1—mediastinal cancer	0.000127	0.00309	CbGpPWpGaD
Vandetanib—LCK—Hemostasis—PTPN1—mediastinal cancer	0.000119	0.00291	CbGpPWpGaD
Vandetanib—ERBB3—Immune System—PTPN1—mediastinal cancer	0.000117	0.00284	CbGpPWpGaD
Vandetanib—ABCC1—lymph node—mediastinal cancer	0.000106	0.00111	CbGeAlD
Vandetanib—SRC—Hemostasis—PTPN1—mediastinal cancer	0.000106	0.00257	CbGpPWpGaD
Vandetanib—YES1—Immune System—PTPN1—mediastinal cancer	0.000102	0.00249	CbGpPWpGaD
Vandetanib—ABCG2—lymph node—mediastinal cancer	8.78e-05	0.00092	CbGeAlD
Vandetanib—RIPK2—Signaling Pathways—PTPN1—mediastinal cancer	8.55e-05	0.00208	CbGpPWpGaD
Vandetanib—MAP2K5—Signaling Pathways—PTPN1—mediastinal cancer	7.82e-05	0.00191	CbGpPWpGaD
Vandetanib—PDGFRB—Immune System—PTPN1—mediastinal cancer	7.79e-05	0.0019	CbGpPWpGaD
Vandetanib—LYN—Immune System—PTPN1—mediastinal cancer	7.63e-05	0.00186	CbGpPWpGaD
Vandetanib—KDR—Signaling Pathways—PTPN1—mediastinal cancer	7.62e-05	0.00186	CbGpPWpGaD
Vandetanib—ABL1—Immune System—PTPN1—mediastinal cancer	7.59e-05	0.00185	CbGpPWpGaD
Vandetanib—ERBB3—Signaling Pathways—PTPN1—mediastinal cancer	7.54e-05	0.00184	CbGpPWpGaD
Vandetanib—FYN—Immune System—PTPN1—mediastinal cancer	7.51e-05	0.00183	CbGpPWpGaD
Vandetanib—ALB—Hemostasis—PTPN1—mediastinal cancer	7.13e-05	0.00174	CbGpPWpGaD
Vandetanib—VEGFA—Signaling Pathways—PTPN1—mediastinal cancer	6.85e-05	0.00167	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—PTPN1—mediastinal cancer	6.62e-05	0.00161	CbGpPWpGaD
Vandetanib—EGFR—Immune System—PTPN1—mediastinal cancer	6.49e-05	0.00158	CbGpPWpGaD
Vandetanib—LCK—Immune System—PTPN1—mediastinal cancer	6.25e-05	0.00152	CbGpPWpGaD
Vandetanib—SRC—Immune System—PTPN1—mediastinal cancer	5.54e-05	0.00135	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—PTPN1—mediastinal cancer	5.04e-05	0.00123	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—PTPN1—mediastinal cancer	4.93e-05	0.0012	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—PTPN1—mediastinal cancer	4.86e-05	0.00118	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—PTPN1—mediastinal cancer	4.2e-05	0.00102	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—PTPN1—mediastinal cancer	4.04e-05	0.000985	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—PTPN1—mediastinal cancer	3.58e-05	0.000872	CbGpPWpGaD
